Search results

Validation Data

Status: Open.

#36 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Jan 24, 2023

Mutation Shared Proportion vs. RNA-seq

Status: Open.

#35 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Sep 21, 2022

Mutation Shared Proportion

Status: Open.

#31 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Apr 13, 2022

TCR sequencing with MiXCR

Status: Open.

#29 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Apr 7, 2022

CNV burden vs. Immune infiltration

Status: Open.

#28 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Apr 4, 2022

Gene fusion plot

Status: Open.

#26 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Dec 29, 2021

Mobster

Status: Open.

#24 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Dec 20, 2021

Gene expression changing upon clinical data

Status: Open.

#21 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Nov 8, 2021

Copy Number Variation -- depth ratio & CNt

Status: Open.

#20 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Oct 20, 2021

Recur vs. Non-recur analysis with WES data

Status: Open.

#19 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Oct 20, 2021

Mutational signature analysis

Status: Open.

#18 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Oct 20, 2021

Overall survival comparison

Status: Open.

#14 In CompbioLabUnist/UNIST-LungCancer-INHA;

· Fumire opened on Oct 5, 2021